Published in Exp Brain Res on January 31, 2008
Resting interhemispheric functional magnetic resonance imaging connectivity predicts performance after stroke. Ann Neurol (2010) 2.89
Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load. Brain (2009) 2.28
Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies. J Magn Reson Imaging (2012) 1.86
Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain (2010) 1.12
Altered functional connectivity in the motor network after traumatic brain injury. Neurology (2010) 1.00
An animal model of cortical and callosal pathology in multiple sclerosis. Brain Pathol (2010) 0.97
Neuroplasticity and functional recovery in multiple sclerosis. Nat Rev Neurol (2012) 0.93
Effects of aerobic fitness on aging-related changes of interhemispheric inhibition and motor performance. Front Aging Neurosci (2013) 0.93
Imaging network level language recovery after left PCA stroke. Restor Neurol Neurosci (2016) 0.83
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis. PLoS One (2013) 0.79
Potential enhancing effects of histamine H₁ agonism/H₃ antagonism on working memory assessed by performance and bold response in healthy volunteers. Br J Pharmacol (2013) 0.79
The Role of fMRI to Assess Plasticity of the Motor System in MS. Front Neurol (2015) 0.79
Inter-hemispheric functional connectivity changes with corpus callosum morphology in multiple sclerosis. Neuroscience (2014) 0.78
Neuroplastic changes in resting-state functional connectivity after stroke rehabilitation. Front Hum Neurosci (2015) 0.78
Task Dependence, Tissue Specificity, and Spatial Distribution of Widespread Activations in Large Single-Subject Functional MRI Datasets at 7T. Cereb Cortex (2014) 0.77
Multi-task functional MRI in multiple sclerosis patients without clinical disability. Neuroimage (2011) 0.77
Altered callosal function in cerebral microangiopathy. J Neurol (2009) 0.76
Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis. PLoS One (2016) 0.75
How changes in brain activity and connectivity are associated with motor performance in people with MS. Neuroimage Clin (2017) 0.75
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64
Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage (2002) 38.46
A global optimisation method for robust affine registration of brain images. Med Image Anal (2001) 27.87
Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med (1995) 21.06
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A (2004) 19.84
Investigations into resting-state connectivity using independent component analysis. Philos Trans R Soc Lond B Biol Sci (2005) 16.87
Wandering minds: the default network and stimulus-independent thought. Science (2007) 12.30
fMRI resting state networks define distinct modes of long-distance interactions in the human brain. Neuroimage (2005) 8.61
A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging. J Cogn Neurosci (2003) 8.45
Localization of the motor hand area to a knob on the precentral gyrus. A new landmark. Brain (1997) 7.24
Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage (2004) 6.87
Conceptual processing during the conscious resting state. A functional MRI study. J Cogn Neurosci (1999) 6.67
Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1. Nat Neurosci (2006) 4.67
Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum Brain Mapp (2005) 4.11
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol (2006) 2.93
Functional MRI cerebral activation and deactivation during finger movement. Neurology (2000) 2.40
Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes. Lancet Neurol (2005) 2.01
Hemodynamic and metabolic responses to neuronal inhibition. Neuroimage (2004) 1.88
Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis? Brain (1999) 1.56
Males and females differ in brain activation during cognitive tasks. Neuroimage (2005) 1.47
Interhemispheric asymmetry of the human motor cortex related to handedness and gender. Neuropsychologia (2000) 1.43
Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis. Brain (2005) 1.28
The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. Ann Neurol (2000) 1.26
MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol (2005) 1.26
Effect of corpus callosum damage on ipsilateral motor activation in patients with multiple sclerosis: a functional and anatomical study. Hum Brain Mapp (2007) 1.21
Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis. Neuroimage (2007) 1.19
Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Brain (2000) 1.16
Alzheimer's patients engage an alternative network during a memory task. Ann Neurol (2005) 1.13
Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Hum Brain Mapp (2003) 1.07
Cortical motor reorganization after a single clinical attack of multiple sclerosis. Brain (2002) 1.05
Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability. Brain (2002) 1.05
The neural correlates of consciousness: an analysis of cognitive skill learning. Philos Trans R Soc Lond B Biol Sci (1998) 1.00
A longitudinal fMRI study on motor activity in patients with multiple sclerosis. Brain (2005) 0.98
Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Ann Neurol (2002) 0.96
Relating axonal injury to functional recovery in MS. Neurology (2000) 0.95
Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy. Exp Brain Res (2006) 0.91
Correlations between structural CNS damage and functional MRI changes in primary progressive MS. Neuroimage (2002) 0.91
Contribution of corticospinal tract damage to cortical motor reorganization after a single clinical attack of multiple sclerosis. Neuroimage (2002) 0.90
Altered functional connectivity related to white matter changes inside the working memory network at the very early stage of MS. J Cereb Blood Flow Metab (2005) 0.90
Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement--EEG evidence. Neuroimage (2001) 0.86
Distinct mechanisms of altered brain activation in patients with multiple sclerosis. Neuroimage (2007) 0.86
Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage (2003) 0.84
Evidence for widespread movement-associated functional MRI changes in patients with PPMS. Neurology (2002) 0.83
An expanded cortical representation for hand movement after peripheral motor denervation. J Neurol Neurosurg Psychiatry (2002) 0.82
Pyramidal tract lesions and movement-associated cortical recruitment in patients with MS. Neuroimage (2004) 0.82
Neural basis for verb processing in Alzheimer's disease: an fMRI study. Neuropsychology (2003) 0.81
A functional magnetic resonance imaging study of patients with secondary progressive multiple sclerosis. Neuroimage (2003) 0.80
A functional MRI study of cortical activations associated with object manipulation in patients with MS. Neuroimage (2004) 0.80
Simple and complex movement-associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Hum Brain Mapp (2004) 0.79
A global optimisation method for robust affine registration of brain images. Med Image Anal (2001) 27.87
Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging (2001) 25.22
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A (2006) 19.60
Entropic elasticity of lambda-phage DNA. Science (1994) 15.40
A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (1995) 15.20
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60
Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med (2003) 12.09
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55
Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci (2003) 10.44
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
Large-scale temporal gene expression mapping of central nervous system development. Proc Natl Acad Sci U S A (1998) 9.06
fMRI resting state networks define distinct modes of long-distance interactions in the human brain. Neuroimage (2005) 8.61
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol (1987) 8.48
The CATH database: an extended protein family resource for structural and functional genomics. Nucleic Acids Res (2003) 8.36
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage (2002) 8.03
Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol (2007) 7.30
Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta (1982) 7.13
Changes in energy expenditure resulting from altered body weight. N Engl J Med (1995) 7.03
Structural basis of cell-cell adhesion by cadherins. Nature (1995) 6.56
Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Cell (1991) 6.28
Spectrographic data concerning vitamin A and liver oils. Biochem J (1931) 6.14
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (1999) 5.62
Methods for the determination of adipose cell size in man and animals. J Lipid Res (1968) 5.47
Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell (1992) 5.29
Reduced resting-state brain activity in the "default network" in normal aging. Cereb Cortex (2007) 5.28
Ethics and late termination of pregnancy. Lancet (1993) 4.85
X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. Science (1999) 4.78
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Hydroxyproline arabinosides in the plant kingdom. Plant Physiol (1971) 4.67
Ethical issues in the design and conduct of randomised controlled trials. Health Technol Assess (1998) 4.55
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet (2001) 4.55
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol (2001) 4.54
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology (2006) 4.38
Dissociating pain from its anticipation in the human brain. Science (1999) 4.36
Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation (1991) 4.30
Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature (1996) 4.25
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology (2011) 4.25
Changes in connectivity profiles define functionally distinct regions in human medial frontal cortex. Proc Natl Acad Sci U S A (2004) 4.19
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry (1992) 4.16
Effect of using protocols on medical care: randomised trial of three methods of taking an antenatal history. BMJ (1992) 4.07
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med (2000) 3.98
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology (2010) 3.98
Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA (2000) 3.87
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
A cytogenetic survey of 14,069 newborn infants. I. Incidence of chromosome abnormalities. Clin Genet (1975) 3.81
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Altered electrical properties in Drosophila neurons developing without synaptic transmission. J Neurosci (2001) 3.80
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology (2012) 3.79
A number of different nuclear genes for the small subunit of RuBPCase are transcribed in petunia. Nucleic Acids Res (1983) 3.56
The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain (2001) 3.51
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology (2005) 3.45
Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. Nature (1991) 3.43
Obesity. N Engl J Med (1997) 3.43
Randomised trial comparing a policy of early with selective amniotomy in uncomplicated labour at term. Br J Obstet Gynaecol (1997) 3.37
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. Lancet Neurol (2009) 3.37
Meiotic gene conversion and crossing over: their relationship to each other and to chromosome synapsis and segregation. Cell (1990) 3.36
Simple correction method for k-space trajectory deviations in MRI. J Magn Reson (1998) 3.35
Giardia and Cryptosporidium join the 'Neglected Diseases Initiative'. Trends Parasitol (2006) 3.34
Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex (1999) 3.31
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage (2004) 3.25
Genetic heterogeneity and mitochondrial DNA heteroplasmy in Leber's hereditary optic neuropathy. J Med Genet (1989) 3.25
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.21
The crystal structure of dimeric kinesin and implications for microtubule-dependent motility. Cell (1997) 3.17
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci (1993) 3.16
The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain (1987) 3.15
Central nervous system sarcoidosis--diagnosis and management. QJM (1999) 3.11
The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest (1968) 3.11
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene (2006) 3.09
The next ten years of health spending: what does the future hold? The Health Expenditures Projection Team. Health Aff (Millwood) (1998) 3.04
Stigmatization of AIDS patients by physicians. Am J Public Health (1987) 3.03
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res (1993) 2.99
Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology (1996) 2.94
Informed consent for clinical trials: in search of the "best" method. Soc Sci Med (1998) 2.90
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients. Neurology (2007) 2.88
Cellularity of obese and nonobese human adipose tissue. Fed Proc (1970) 2.86